Celcuity, Inc. (NASDAQ:CELC – Get Free Report)’s share price gapped up before the market opened on Wednesday. The stock had previously closed at $77.38, but opened at $81.30. Celcuity shares last traded at $79.5330, with a volume of 974,203 shares trading hands.
Wall Street Analyst Weigh In
A number of brokerages have weighed in on CELC. Wall Street Zen downgraded Celcuity from a “sell” rating to a “strong sell” rating in a report on Saturday, August 15th. Needham & Company LLC cut their price target on Celcuity from $157.00 to $140.00 and set a “buy” rating on the stock in a report on Friday, August 14th. Citizens Jmp reaffirmed a “market outperform” rating and set a $177.00 price objective on shares of Celcuity in a research report on Monday, August 17th. HC Wainwright reiterated a “buy” rating and issued a $155.00 price objective on shares of Celcuity in a research note on Friday, August 14th. Finally, JPMorgan Chase & Co. began coverage on shares of Celcuity in a research report on Thursday, September 17th. They set an “overweight” rating and a $157.00 target price on the stock. Eleven analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $154.75.
Read Our Latest Analysis on CELC
Celcuity Stock Performance
Celcuity (NASDAQ:CELC – Get Free Report) last posted its quarterly earnings results on Thursday, August 13th. The company reported ($1.44) earnings per share for the quarter, missing analysts’ consensus estimates of ($1.16) by ($0.28). Equities research analysts predict that Celcuity, Inc. will post -4.82 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Celcuity
Several hedge funds and other institutional investors have recently modified their holdings of CELC. Avoro Capital Advisors LLC bought a new position in shares of Celcuity in the 4th quarter worth $310,302,000. Bank of America Corp DE acquired a new position in Celcuity during the second quarter worth $153,928,000. Wellington Management Group LLP raised its holdings in Celcuity by 111.4% during the second quarter. Wellington Management Group LLP now owns 906,595 shares of the company’s stock worth $94,848,000 after buying an additional 477,643 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of Celcuity by 8.4% in the fourth quarter. Geode Capital Management LLC now owns 830,684 shares of the company’s stock valued at $82,872,000 after buying an additional 64,213 shares in the last quarter. Finally, Capitolis Liquid Global Markets LLC bought a new position in shares of Celcuity in the fourth quarter valued at $35,428,000. Institutional investors own 63.33% of the company’s stock.
About Celcuity
Celcuity, Inc is a biotechnology company focused on advancing personalized medicine through functional diagnostics. Its technology is designed to analyze living tumor cells obtained from patient tissue and identify abnormal signaling activity that may influence how a cancer responds to specific therapies.
The company’s primary platform, CELsignia, uses proprietary assays to measure the activity of cellular signaling pathways in a patient’s tumor cells. Celcuity develops these tests for use in oncology drug development, patient selection, and potentially as companion diagnostics to help identify patients who are most likely to benefit from targeted treatments.
Celcuity works with biopharmaceutical companies and research organizations to evaluate drug-response biomarkers and support precision oncology programs.
Featured Articles
- Five stocks we like better than Celcuity
- AI Uncertainty Is Rising, But These 3 Chip ETFs Still Have Momentum
- Arhaus Has New Momentum—Could Other Furniture Stocks Be Next?
- Can Boxabl Turn Modular Homes Into AI Data Center Infrastructure?
- Up All Night: How Nasdaq’s 23-Hour Trading Could Wake Up Wall Street
Receive News & Ratings for Celcuity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celcuity and related companies with MarketBeat.com's FREE daily email newsletter.
